OWA
BIIB icon

Opal Wealth Advisors’s Biogen BIIB Stock Holding History

Opal Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-256
Closed -$46.9K – 266
2026
Q1 		$46.9K Buy
+256
New +$47.2K 0.01% 414
2025
Q3 		– Sell
-186
Closed -$23.4K – 235
2025
Q2 		$23.4K Sell
186
-5
-3% -$623 0.01% 537
2025
Q1 		$26.1K Buy
+191
New +$27.3K 0.01% 474
2024
Q3 		– Sell
-197
Closed -$45.7K – 299
2024
Q2 		$45.7K Buy
+197
New +$42.8K 0.01% 365

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Opal Wealth Advisors's BIIB Position: Q2 2026 in Review

Opal Wealth Advisors sold out of Biogen (BIIB) in Q2 2026, closing a stake of 256 shares — an estimated $46.9K sold.

Opal Wealth Advisors first reported a position in BIIB in Q2 2024 and held it in 4 quarters. The position peaked at $46.9K in Q1 2026. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Opal Wealth Advisors reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Opal Wealth Advisors sold 256 Biogen shares in Q2 2026, an estimated $46.9K.
  • Opal Wealth Advisors first reported a position in Biogen in Q2 2024 and held it in 4 quarters.
  • Opal Wealth Advisors's Biogen position peaked at $46.9K in Q1 2026.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.